Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, January 7, 2026 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a ...
Lysoway Therapeutics, Inc., a biotechnology company advancing structure-guided small-molecule modulators of lysosomal ion ...
(Nanowerk News) Liquid-crystal (LC) phase modulators are widely used in optical systems because of their advantages of low power consumption, light weight, flexible bandwidth adjustment, and ...
1d
Gain Therapeutics Highlights Biomarker Evidence Supporting Disease-Modifying Potential of GT-02287
Results from a Phase 1 study of GT-02287 in healthy volunteers demonstrated favorable safety and tolerability, plasma and CNS exposures in the projected therapeutic range, and target engagement with ...
LASER COMPONENTS is excited to announce groundbreaking low Vπ LiNbO3 phase modulators from Exail, designed for high-power laser applications. Targeted at Coherent Beam Combining (CBC) and Spectral ...
This modulator offers unique performance and outperforms all other modulation solutions available on the market: This Modulator, NIR-MPZ-LN-20, is the most advanced large bandwidth Near-Infra-Red ...
A new microchip-sized device could dramatically accelerate the future of quantum computing. It controls laser frequencies ...
Addex spin-out Neurosterix begins phase 1 study with M4 PAM - NTX-253 for schizophrenia: Geneva, Switzerland Thursday, January 8, 2026, 12:00 Hrs [IST] Addex Therapeutics, a clini ...
(a) The process for fabricating LC phase modulator with the MMOT structure. (b) The schematic of LC phase modulator with MMOT structure. Liquid-crystal (LC) phase modulators are widely used in optical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback